2011
PROINFLAMMATORY AND “RESILIENCY” PROTEINS IN THE CSF OF PATIENTS WITH MAJOR DEPRESSION
Martinez JM, Garakani A, Yehuda R, Gorman JM. PROINFLAMMATORY AND “RESILIENCY” PROTEINS IN THE CSF OF PATIENTS WITH MAJOR DEPRESSION. Depression And Anxiety 2011, 29: 32-38. PMID: 21898706, DOI: 10.1002/da.20876.Peer-Reviewed Original ResearchMeSH KeywordsAdultAntidepressive Agents, Second-GenerationBrain-Derived Neurotrophic FactorCyclohexanolsDepressive Disorder, MajorFemaleHumansInflammationInflammation MediatorsInterleukin-1Interleukin-6MaleMiddle AgedNeuropeptide YSeverity of Illness IndexTumor Necrosis Factor-alphaUp-RegulationVenlafaxine HydrochlorideConceptsInflammatory cytokinesDepressed patientsHealthy controlsMajor depressionCSF cytokine levelsCSF of patientsCerebrospinal fluid levelsLumbar puncture procedureNormal comparison groupInflammatory hypothesisNPY concentrationsNPY levelsCytokine levelsIL-6Lumbar punctureClinical severityTreatment protocolIL-1CSF samplesPatientsNeuroprotective peptideFluid levelsSuicidal ideationPuncture procedureSmall sample size
2003
Comorbidity of Irritable Bowel Syndrome in Psychiatric Patients: A Review
Garakani A, Win T, Virk S, Gupta S, Kaplan D, Masand PS. Comorbidity of Irritable Bowel Syndrome in Psychiatric Patients: A Review. American Journal Of Therapeutics 2003, 10: 61-67. PMID: 12522523, DOI: 10.1097/00045391-200301000-00014.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsIrritable bowel syndromePsychiatric patientsBowel syndromeChronic abdominal discomfortFunctional gastrointestinal disordersU.S. adult populationStool frequencyAbdominal bloatingAbdominal discomfortPresence of mucusGastrointestinal disordersPsychiatric comorbidityMajor depressionHigh prevalencePanic disorderPatientsAdult populationComorbiditiesAnxiety disordersSyndromeDisordersPrevalenceTreatmentRecent studiesBloating